Browse by Audience
Skip to content
Papers of the Week
The endocannabinoid system in migraine: from bench to pharmacy and back.
Authors
Abstract
Migraine is a common, highly disabling disorder. Its treatment involves acute and preventive therapy. Many of available preventive medications are not well tolerated, which results in poor compliance and limited effectiveness. Cannabinoids have been proposed for the treatment of migraine but their efficacy and tolerability are controversial.